TEM
Healthcare
Tempus Grew Revenue 23%, But A $42.8 Million Securities Gain Helped The Loss
Tempus grew revenue 23% and adjusted EBITDA to $25.6M, but a $42.8M unrealized gain materially improved the GAAP loss while operating cash remained negative.